XLAB$2.15+5.60%
Exascale Labs Holdings Inc.
Sector: Services-Prepackaged SoftwareIndustry: Software - InfrastructureCountry: USExchange: Nasdaq
Mkt Cap:$138.59M
Float & O/S:1.52M / 33.69M
Inst Own:Not measured
DilutionScan read 25 of Exascale Labs Holdings Inc.'s SEC filings and found 2 warrant series, 1 convertible and 1 S-1 registration on file for XLAB. The latest dilution event on file is a registration statement on Oct 30, 2026. Analysis updated Oct 30, 2026.
Signal8 Summary
XLAB
Fast-growing but deeply unprofitable, dilution-heavy micro-cap
- Business
- WeakLoss $12.2M vs $14.8M revenue, 16.3% gross margin
- Stock risk
- HighFresh SPAC, 133.8% potential dilution, $87.5M micro-cap
Snapshot
Exascale Labs is a newly public AI-infrastructure company that just completed a SPAC merger and began Nasdaq trading in August 2026. FY2026 revenue grew 111% to $14.8M, a genuine growth signal, but the net loss widened to $12.2M, close to the entire revenue base, and gross margin is thin at 16.3%.
What's Happening Right Now
- : On Sep 28, 2026, Exascale reported FY2026 revenue of $14.8M (up 111% YoY), but net loss widened to $12.2M from $7.7M, with gross margin only 16.3% and pre-deal cash of $2.7M plus ~$11.8M in merger proceeds.
- : Exascale named its post-closing board on Sep 22, 2026, including Nobel laureate David Card as Lead Independent Director, a governance move with no direct financial impact.
- : Exascale signed a non-binding LOI with Compal Electronics on Sep 14, 2026 to jointly develop an 800 VDC GPU validation platform, with commercial terms still to be finalized.
- : Exascale and EnergyBank signed a non-binding MOU on Aug 31, 2026 to pair offshore wind power with Exascale's AI compute infrastructure, targeting up to 10MW of compute per turbine.
- : Exascale Labs completed its business combination with D. Boral ARC Acquisition I Corp. on Aug 27, 2026, beginning Nasdaq trading as XLAB.
- : Closed an offering. Proceeds are not disclosed in the filings reviewed.
- : Issued warrants over 14.10M shares across 2 series.
- : Registered additional securities for sale on Form S-1.
